Vaxxinity, Inc. (VAXX) | 25.28% | $0.70M | N/A | N/A | N/A |
Coeptis Therapeutics Holdings, Inc. (BHSE) | 2.62% | $30.80M | N/A | N/A | N/A |
eFFECTOR Therapeutics, Inc. (EFTR) | 2.30% | $0.00M | N/A | N/A | N/A |
Precigen, Inc. (PGEN) | 1.80% | $532.22M | -36.95% | -86.65% | 60.04 |
INmune Bio, Inc. (INMB) | 1.41% | $215.92M | -100.00% | N/A | 1,861.00 |
Invivyd, Inc. (ADGI) | 1.27% | $88.53M | N/A | 81.36% | -0.61 |
Trevi Therapeutics, Inc. (TRVI) | 1.25% | $625.53M | N/A | N/A | N/A |
Verastem, Inc. (VSTM) | 1.24% | $342.39M | N/A | 99.74% | 13.81 |
MiNK Therapeutics, Inc. (INKT) | 1.22% | $36.06M | N/A | N/A | N/A |
Xeris Biopharma Holdings, Inc. (XERS) | 1.19% | $894.39M | 23.89% | 76.52% | 3.43 |
Heron Therapeutics, Inc. (HRTX) | 1.16% | $362.54M | 13.57% | 73.21% | 2.44 |
OncoCyte Corp. (OCX) | 1.16% | $71.61M | -73.19% | -233.04% | 56.01 |
Galectin Therapeutics, Inc. (GALT) | 1.12% | $99.07M | N/A | N/A | N/A |
Gain Therapeutics, Inc. (GANX) | 1.12% | $62.07M | N/A | N/A | N/A |
Aldeyra Therapeutics, Inc. (ALDX) | 1.05% | $392.88M | N/A | N/A | N/A |
Champions Oncology, Inc. (CSBR) | 1.03% | $132.46M | 41.77% | 61.17% | N/A |
LAVA Therapeutics NV (LVTX) | 0.97% | $34.18M | -100.00% | N/A | -3.82 |
CorMedix, Inc. (CRMD) | 0.97% | $661.99M | N/A | 94.01% | 35.05 |
MeiraGTx Holdings Plc (MGTX) | 0.95% | $596.14M | 137.42% | -10.04% | 12.21 |
IO Biotech, Inc. (IOBT) | 0.94% | $63.24M | N/A | N/A | N/A |
AlloVir, Inc. (ALVR) | 0.94% | $55.45M | N/A | N/A | N/A |
Anixa Biosciences, Inc. (ANIX) | 0.90% | $101.74M | N/A | N/A | N/A |
Solid Biosciences, Inc. (SLDB) | 0.87% | $356.47M | N/A | N/A | N/A |
Precision BioSciences, Inc. (DTIL) | 0.87% | $43.01M | -95.61% | -75.52% | -0.07 |
ImmuCell Corp. (ICCC) | 0.85% | $43.76M | 51.63% | 29.97% | N/A |
ImmunoPrecise Antibodies Ltd. (IPA) | 0.85% | $19.37M | -0.98% | 46.11% | 1.28 |
Vistagen Therapeutics, Inc. (VTGN) | 0.85% | $80.53M | -43.12% | 31.20% | N/A |
Vigil Neuroscience, Inc. (VIGL) | 0.83% | $88.21M | N/A | N/A | N/A |
Cyclo Therapeutics, Inc. (CYTH) | 0.82% | $20.14M | -52.82% | -268.79% | 38.98 |
Rani Therapeutics Holdings, Inc. (RANI) | 0.82% | $88.80M | N/A | N/A | N/A |
Compugen Ltd. (CGEN) | 0.80% | $146.82M | -16.72% | 71.54% | 1.31 |
Monte Rosa Therapeutics, Inc. (GLUE) | 0.78% | $356.76M | N/A | 89.26% | 2.43 |
CARA Therapeutics, Inc. (CARA) | 0.78% | $26.07M | -65.96% | 88.62% | 4.83 |
Shattuck Labs, Inc. (STTK) | 0.77% | $57.29M | 336.88% | 68.20% | 14.14 |
Carisma Therapeutics, Inc. (SESN) | 0.76% | $17.27M | -11.55% | 78.23% | 0.85 |
Vor Biopharma, Inc. (VOR) | 0.75% | $108.62M | N/A | N/A | N/A |
Instil Bio, Inc. (TIL) | 0.73% | $116.75M | N/A | N/A | N/A |
Cue Biopharma, Inc. (CUE) | 0.73% | $62.37M | 58.86% | 73.65% | 1.67 |
Replimune Group, Inc. (REPL) | 0.71% | $833.30M | N/A | N/A | N/A |
iTeos Therapeutics, Inc. (ITOS) | 0.71% | $262.78M | 177.89% | 96.46% | -5.11 |
Taysha Gene Therapies, Inc. (TSHA) | 0.71% | $336.20M | -46.07% | 85.06% | 42.87 |
Greenwich LifeSciences, Inc. (GLSI) | 0.70% | $146.04M | N/A | N/A | N/A |
Vaxart, Inc. (VXRT) | 0.70% | $117.64M | 288.94% | 84.67% | 3.67 |
Curis, Inc. (CRIS) | 0.68% | $22.52M | 3.46% | 97.17% | 4.91 |
Enlivex Therapeutics Ltd. (ENLV) | 0.68% | $22.98M | N/A | N/A | N/A |
Kezar Life Sciences, Inc. (KZR) | 0.67% | $43.00M | -100.00% | N/A | N/A |
Black Diamond Therapeutics, Inc. (BDTX) | 0.65% | $100.86M | N/A | N/A | N/A |
Ikena Oncology, Inc. (IKNA) | 0.65% | $55.15M | -100.00% | N/A | N/A |
Spruce Biosciences, Inc. (SPRB) | 0.64% | $13.90M | -80.41% | 98.34% | -5.24 |
uniQure NV (QURE) | 0.63% | $740.85M | 71.17% | -14.19% | 36.60 |
Seer, Inc. (California) (SEER) | 0.63% | $112.39M | -8.13% | 4.70% | -4.76 |
Spero Therapeutics, Inc. (SPRO) | 0.63% | $44.82M | -66.56% | N/A | 0.01 |
Graphite Bio, Inc. (GRPH) | 0.62% | $728.96M | N/A | N/A | N/A |
Foghorn Therapeutics, Inc. (FHTX) | 0.62% | $225.23M | -33.83% | 86.20% | 2.32 |
Seres Therapeutics, Inc. (MCRB) | 0.61% | $124.02M | -100.00% | N/A | N/A |
Immunome, Inc. (IMNM) | 0.61% | $711.26M | -35.50% | 76.75% | 45.38 |
Quince Therapeutics, Inc. (CRTX) | 0.59% | $60.72M | N/A | N/A | N/A |
Spyre Therapeutics, Inc. (AGLE) | 0.58% | $1.09B | -100.00% | N/A | N/A |
Affimed NV (AFMD) | 0.58% | $13.52M | -92.02% | N/A | 43.85 |
Design Therapeutics, Inc. (DSGN) | 0.57% | $263.95M | N/A | N/A | N/A |
Compass Pathways Plc (CMPS) | 0.57% | $212.51M | N/A | N/A | N/A |
Nuvation Bio, Inc. (NUVB) | 0.56% | $640.10M | N/A | 1.42% | 28.09 |
Passage Bio, Inc. (PASG) | 0.55% | $31.14M | N/A | N/A | N/A |
Stoke Therapeutics, Inc. (STOK) | 0.55% | $440.73M | 316.34% | 87.85% | 10.49 |
Altimmune, Inc. (ALT) | 0.54% | $447.45M | -95.31% | -1,090.00% | 19,084.13 |
Humacyte, Inc. (HUMA) | 0.53% | $427.18M | N/A | N/A | N/A |
Elutia, Inc. (AZYO) | 0.52% | $165.24M | -1.50% | 43.93% | 5.34 |
Cognition Therapeutics, Inc. (CGTX) | 0.52% | $28.19M | N/A | N/A | N/A |
Voyager Therapeutics, Inc. (VYGR) | 0.52% | $214.20M | 433.79% | 95.40% | 0.23 |
Neoleukin Therapeutics, Inc. (NLTX) | 0.52% | $184.88M | N/A | N/A | 632.96 |
Akoya Biosciences, Inc. (AKYA) | 0.52% | $84.27M | -15.48% | 49.23% | 1.99 |
HCW Biologics Inc. (HCWB) | 0.51% | $13.53M | -50.02% | -10.12% | 9.21 |
Co-Diagnostics, Inc. (CODX) | 0.51% | $14.72M | -91.58% | -213.54% | 0.68 |
Climb Bio, Inc. (ELYM) | 0.50% | $87.49M | N/A | N/A | N/A |
Enzo Biochem, Inc. (ENZ) | 0.49% | $25.47M | -14.25% | 51.61% | N/A |
Nkarta, Inc. (NKTX) | 0.49% | $105.85M | N/A | N/A | N/A |
Larimar Therapeutics, Inc. (LRMR) | 0.48% | $162.07M | N/A | N/A | N/A |
ProKidney Corp. (DNAC) | 0.48% | $281.56M | N/A | -5,606.58% | 15,881.75 |
HOOKIPA Pharma, Inc. (HOOK) | 0.47% | $15.07M | 118.32% | 93.74% | -0.31 |
BioVie, Inc. (BIVI) | 0.46% | $20.67M | N/A | N/A | N/A |
Reneo Pharmaceuticals, Inc. (RPHM) | 0.46% | $67.40M | N/A | N/A | N/A |
Ventyx Biosciences, Inc. (VTYX) | 0.46% | $93.89M | N/A | N/A | N/A |
Agenus, Inc. (AGEN) | 0.45% | $37.77M | -33.81% | 86.63% | 4.54 |
Whitehawk Therapeutics, Inc. (AADI) | 0.44% | $50.63M | 6.69% | 88.36% | 1.50 |
Athira Pharma, Inc. (ATHA) | 0.44% | $12.97M | N/A | N/A | N/A |
Prelude Therapeutics, Inc. (PRLD) | 0.44% | $48.32M | N/A | 74.69% | -2.71 |
Nautilus Biotechnology, Inc. (NAUT) | 0.44% | $124.89M | N/A | N/A | N/A |
InflaRx NV (IFRX) | 0.43% | $85.93M | 162.93% | -2,175.50% | 511.07 |
Fate Therapeutics, Inc. (FATE) | 0.43% | $104.73M | -78.55% | -39.11% | -0.46 |
C4 Therapeutics, Inc. (CCCC) | 0.43% | $150.50M | 71.44% | 77.82% | 1.98 |
XBiotech, Inc. (XBIT) | 0.42% | $104.88M | N/A | N/A | N/A |
TScan Therapeutics, Inc. (TCRX) | 0.42% | $94.51M | -86.62% | -45.88% | 52.46 |
23andMe Holding Co. (ME) | 0.41% | $48.02M | 34.67% | 55.24% | 0.31 |
PepGen Inc. (PEPG) | 0.41% | $57.87M | N/A | N/A | N/A |
Syros Pharmaceuticals, Inc. (SYRS) | 0.40% | $1.65M | -100.00% | N/A | 224.15 |
BioAtla, Inc. (BCAB) | 0.40% | $20.38M | N/A | 97.93% | 2.71 |
Century Therapeutics, Inc. (IPSC) | 0.39% | $47.75M | 194.81% | -101.91% | -8.50 |
X4 Pharmaceuticals, Inc. (XFOR) | 0.38% | $53.37M | N/A | 45.18% | 69.16 |
AVROBIO, Inc. (AVRO) | 0.36% | $311.85M | N/A | N/A | N/A |
Adaptimmune Therapeutics Plc (ADAP) | 0.35% | $74.41M | 467.86% | 93.11% | 0.75 |
BioXcel Therapeutics, Inc. (BTAI) | 0.33% | $7.67M | -37.24% | -482.71% | 39.74 |
Renovaro, Inc. (ENOB) | 0.33% | $113.76M | N/A | N/A | N/A |
Kodiak Sciences, Inc. (KOD) | 0.29% | $172.61M | N/A | N/A | N/A |
Sangamo Therapeutics, Inc. (SGMO) | 0.27% | $194.73M | -67.20% | 83.80% | 3.36 |
SAB Biotherapeutics, Inc. (SABS) | 0.27% | $15.87M | -100.00% | N/A | -0.58 |
Mersana Therapeutics, Inc. (MRSN) | 0.22% | $53.02M | 9.88% | 95.98% | 1.71 |
Bionano Genomics, Inc. (BNGO) | 0.21% | $8.88M | -34.83% | -139.07% | 1.15 |
Jasper Therapeutics, Inc. (JSPR) | 0.20% | $78.27M | N/A | N/A | N/A |
Leap Therapeutics, Inc. (LPTX) | 0.11% | $15.37M | N/A | N/A | N/A |
Aspira Women's Health, Inc. (AWH) | 0.10% | $1.55M | 1.80% | 60.04% | 1.39 |
Nascent Biotech, Inc. (NBIO) | 0.07% | $0.77M | N/A | N/A | N/A |
Omega Therapeutics, Inc. (OMGA) | 0.01% | $0.63M | 214.32% | -18.64% | 20.35 |
Gritstone bio, Inc. (GRTS) | 0.01% | $0.00M | -85.75% | -2,707.02% | 270.26 |